- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT02571452
Brief Behavioral Insomnia Treatment Study (BBTI)
2020년 1월 28일 업데이트: VA Office of Research and Development
Telephone-Facilitated Insomnia Treatment in Primary Care for OEF/OIF/OND Veterans
The purpose of this study is to determine whether a brief, behavioral treatment for insomnia is effective in addressing social and occupational functioning and overall health among Veterans with insomnia disorder.
연구 개요
상태
완전한
정황
상세 설명
This study is a randomized, controlled trial of a telephone-based, brief insomnia treatment in primary care in order to accomplish the goal of improving psychosocial functioning in Veterans who meet criteria for Insomnia Disorder.
The primary outcome for the trial will be psychosocial functioning, with insomnia severity serving as the secondary outcome.
Additional goals include evaluating durability of treatment gains and obtaining feedback from participants about the utility and feasibility of the proposed insomnia treatment.
연구 유형
중재적
등록 (실제)
93
단계
- 해당 없음
연락처 및 위치
이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.
연구 장소
-
-
California
-
San Francisco, California, 미국, 94121
- San Francisco VA Medical Center, San Francisco, CA
-
-
참여기준
연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.
자격 기준
공부할 수 있는 나이
18년 (성인, 고령자)
건강한 자원 봉사자를 받아들입니다
아니
연구 대상 성별
모두
설명
Inclusion Criteria:
- Veterans between the ages of 18-75 years.
- Meet DSM-5 Criteria for Insomnia Disorder.
- Able attend in-person appointments at the San Francisco VA Medical Center
The investigators will not exclude individuals who are taking insomnia or antidepressant medications, provided they have been stable on these medications for at least one month and still meet criteria for Insomnia Disorder as described above.
- Specifically, individuals receiving benzodiazepine or benzodiazepine receptor agonists, anticonvulsants, atypical antipsychotic medication, or non-SSRI antidepressant medications such as trazodone will not be excluded provided they meet the criteria described above.
The investigators will not exclude Veterans receiving any type of psychotherapy, provided they have received this treatment for at least three months and do not plan to discontinue this treatment during the BBTI trial.
- However, individual who need to start a new type of psychotherapy during the course of the treatment will be excluded, or they will need to wait three months in order to enroll in the trial.
- The investigators will not exclude individuals with TBI.
- The investigators will not exclude individuals with chronic pain.
- The investigators will not exclude individuals based on any other mental health condition, including posttraumatic stress disorder and depression.
Exclusion Criteria:
- Conditions that may be associated with comorbid insomnia, including a lifetime history of any psychiatric disorder with psychotic features or bipolar disorder, and alcohol or drug dependence within the past year.
- Individuals who meet criteria for alcohol or drug abuse will be asked to reduce alcohol to recommended limits during the course of the study and/or refrain from drug use in order to be included.
- Veterans with suicidal or homicidal ideation.
- Veterans who are pregnant, due to the biological impact of pregnancy on sleep.
- Veterans who work night or rotating shifts.
- Veterans with untreated moderate to severe sleep apnea (those receiving treatment will not be excluded from the study).
공부 계획
이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Brief Behavioral Treatment for Insomnia
Participants will receive 4 weeks of Brief Behavioral Treatment for Insomnia (BBTI).
BBTI consists of two in-person sessions, with the two other sessions conducted via telephone.
BBTI emphasizes behavioral elements of insomnia treatment.
Treatment begins with sleep education and discussion of the biological rhythms that influence sleep cycles.
Next, a series of interventions are employed that are derived from sleep restriction and stimulus control techniques.
|
Participants will receive 4 weeks of Brief Behavioral Treatment for Insomnia (BBTI).
BBTI consists of two in-person sessions, with the two other sessions conducted via telephone.
BBTI emphasizes behavioral elements of insomnia treatment.
Treatment begins with sleep education and discussion of the biological rhythms that influence sleep cycles.
Next, a series of interventions are employed that are derived from sleep restriction and stimulus control techniques.
|
|
활성 비교기: Progressive Muscle Relaxation
Participants will receive 4 weeks of progressive muscle relaxation training (PMRT).
PMRT consists of two in-person and two phone sessions.
Treatment begins with training on muscle tensing and relaxing, and advances to progressively more efficient tensing-relaxing and passive relaxation exercises.
Sessions are employed that teach techniques and problem-solve barriers to the use of PMRT.
|
Participants will receive 4 weeks of progressive muscle relaxation training (PMRT).
PMRT consists of two in-person and two phone sessions.
Treatment begins with training on muscle tensing and relaxing, and advances to progressively more efficient tensing-relaxing and passive relaxation exercises.
Sessions are employed that teach techniques and problem-solve barriers to the use of PMRT.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Work and Social Adjustment Scale (WSAS)
기간: Change from Mid-treatment to Post-treatment (week 3 to week 5), with Baseline as a covariate
|
The WSAS assesses functioning at work, home, management, social leisure activities, private leisure activities, and relationships with others.
Scores range from 0-40, with higher scores meaning greater impairment.
The measure was administered at Baseline (week 0), Mid-treatment (week 3) & Post-treatment (week 5).
|
Change from Mid-treatment to Post-treatment (week 3 to week 5), with Baseline as a covariate
|
|
Work and Social Adjustment Scale (WSAS)
기간: Change from Post-treatment to Follow-up (after 6 months)--for treatment arm only
|
The WSAS assesses functioning at work, home, management, social leisure activities, private leisure activities, and relationships with others.
Scores range from 0-40, with higher scores meaning greater impairment.
The WSAS was administered at Follow-up (6 months Post-treatment) for participants receiving the experimental treatment only.
|
Change from Post-treatment to Follow-up (after 6 months)--for treatment arm only
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Insomnia Severity (ISI)
기간: Change from Mid-treatment to Post-treatment (week 3 to week 5), with Baseline as a covariate
|
The ISI is a specific index of perceived insomnia severity.
Areas assessed include problems with sleep onset, sleep maintenance, and early morning awakening; dissatisfaction with sleep; interference with daily functioning; impact on quality of life; and worry about sleep problems.
Scores range from 0-28, with higher scores meaning greater impairment.
The measure was administered at Baseline (week 0), Mid-treatment (week 3) & Post-treatment (week 5).
|
Change from Mid-treatment to Post-treatment (week 3 to week 5), with Baseline as a covariate
|
|
Insomnia Severity (ISI)
기간: Change from Post-treatment to Follow-up (after 6 months)--for treatment arm only
|
Insomnia Severity Index (ISI) is a specific index of perceived insomnia severity.
Areas assessed include problems with sleep onset, sleep maintenance, and early morning awakening; dissatisfaction with sleep; interference with daily functioning; impact on quality of life; and worry about sleep problems.
Scores range from 0-28, with higher scores meaning greater impairment.
The ISI was administered at Follow-up (6 months Post-treatment) for participants receiving the experimental treatment only.
|
Change from Post-treatment to Follow-up (after 6 months)--for treatment arm only
|
공동 작업자 및 조사자
여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.
간행물 및 유용한 링크
연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.
일반 간행물
- Ranney RM, Gloria R, Metzler TJ, Huggins J, Neylan TC, Maguen S. Brief behavioral treatment for insomnia decreases trauma-related nightmare frequency in veterans. J Clin Sleep Med. 2022 Jul 1;18(7):1831-1839. doi: 10.5664/jcsm.10002.
- Maguen S, Gloria R, Huggins J, Goldstein LA, Kanady JC, Straus LD, Metzler TJ, Lujan C, Neylan TC. Brief behavioral treatment for insomnia improves psychosocial functioning in veterans: results from a randomized controlled trial. Sleep. 2021 Mar 12;44(3):zsaa205. doi: 10.1093/sleep/zsaa205.
연구 기록 날짜
이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.
연구 주요 날짜
연구 시작 (실제)
2016년 1월 6일
기본 완료 (실제)
2019년 3월 31일
연구 완료 (실제)
2019년 6월 30일
연구 등록 날짜
최초 제출
2015년 10월 2일
QC 기준을 충족하는 최초 제출
2015년 10월 6일
처음 게시됨 (추정)
2015년 10월 8일
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
2020년 2월 7일
QC 기준을 충족하는 마지막 업데이트 제출
2020년 1월 28일
마지막으로 확인됨
2020년 1월 1일
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .